𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population

✍ Scribed by Jack Hadley; Daniel Polsky; Jeanne S. Mandelblatt; Jean M. Mitchell; Jane C. Weeks; Qin Wang; Yi-Ting Hwang


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
153 KB
Volume
12
Category
Article
ISSN
1057-9230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

This study is motivated by the potential problem of using observational data to draw inferences about treatment outcomes when experimental data are not available. We compare two statistical approaches, ordinary least‐squares (OLS) and instrumental variables (IV) regression analysis, to estimate the outcomes (three‐year post‐treatment survival) of three treatments for early stage breast cancer in elderly women: mastectomy (MST), breast conserving surgery with radiation therapy (BCSRT), and breast conserving surgery only (BCSO). The primary data source was Medicare claims for a national random sample of 2907 women (age 67 or older) with localized breast cancer who were treated between 1992 and 1994.

Contrary to randomized clinical trial (RCT) results, analysis with the observational data found highly significant differences in survival among the three treatment alternatives: 79.2% survival for BCSO, 85.3% for MST, and 93.0% for BCSRT. Using OLS to control for the effects of observable characteristics narrowed the estimated survival rate differences, which remained statistically significant. In contrast, the IV analysis estimated survival rate differences that were not significantly different from 0. However, the IV‐point estimates of the treatment effects were quantitatively larger than the OLS estimates, unstable, and not significantly different from the OLS results. In addition, both sets of estimates were in the same quantitative range as the RCT results.

We conclude that unadjusted observational data on health outcomes of alternative treatments for localized breast cancer should not be used for cost‐effectiveness studies. Our comparisons suggest that whether one places greater confidence in the OLS or the IV results depends on at least three factors: (1) the extent of observable health information that can be used as controls in OLS estimation, (2) the outcomes of statistical tests of the validity of the instrumental variable method, and (3) the similarity of the OLS and IV estimates. In this particular analysis, the OLS estimates appear to be preferable because of the instability of the IV estimates. Copyright © 2002 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Use of instrumental variables in the pre
✍ Anirban Basu; James J. Heckman; Salvador Navarro-Lozano; Sergio Urzua 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 2 views

## Abstract Instrumental variable (IV) methods are widely used in the health economics literature to adjust for hidden selection biases in observational studies when estimating treatment effects. Less attention has been paid in the applied literature to the proper use of IVs if treatment effects ar

Functional variants in the promoter of i
✍ Jiyong Liu; Xiangjun Zhai; Guangfu Jin; Zhibin Hu; Shui Wang; Xuechen Wang; Jian 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 91 KB 👁 1 views

## Abstract Interleukin 1β (IL‐1β) is a multifunctional cytokine that upregulates the inflammatory response, and participates in carcinogenesis, malignant transformation, tumor growth, invasion and metastasis. Two potentially functional polymorphisms (T‐31C and C‐511T) in the __IL‐1__β gene promote